---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-216745"
form_type: "8-K"
ticker: "ANAB"
cik: "0001370053"
company_name: "ANAPTYSBIO, INC"
filed_at: "2026-05-11T20:05:24+00:00"
generated_at: "2026-05-11T22:51:16.951019+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# AnaptysBio appoints Christopher Murphy CFO ($42,917/mo) and Owen Hughes to board

## Summary
- Christopher Murphy appointed CFO effective May 11, 2026; previously CFO at Third Harmonic Bio and Horizon Therapeutics.
- Murphy's consulting agreement: $42,916.66 monthly fee, target bonus up to 40% of annual fees, and $1.75M RSU grant vesting over 4 years.
- Owen Hughes appointed Class I director effective May 11, 2026; receives initial grant of 11,250 RSUs vesting over 3 years.
- Murphy serves as independent contractor; severance provides 9-12 months fee continuation based on termination cause.

## SEC filing metadata
- accession: 0001193125-26-216745
- form_type: 8-K
- ticker: ANAB
- cik: 0001370053
- company_name: ANAPTYSBIO, INC
- filed_at: 2026-05-11T20:05:24+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1370053/000119312526216745/0001193125-26-216745-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1370053/000119312526216745/anab-20260511.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-216745
- JSON: https://secwatch.observer/filing/0001193125-26-216745.json
- Plain text: https://secwatch.observer/filing/0001193125-26-216745.txt

## Key facts
- Executive change
  Christopher M. Murphy was appointed as Chief Financial Officer at ANAPTYSBIO, INC.
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On May 11, 2026, AnaptysBio, Inc. (the “Company”) announced that its Board of Directors (the “Board”) appointed Christopher M. Murphy as Chief Financial Officer, effective as of May 11, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1370053/000119312526216745/0001193125-26-216745-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.